Thomas Schwarzl

5.6k total citations · 2 hit papers
31 papers, 3.3k citations indexed

About

Thomas Schwarzl is a scholar working on Molecular Biology, Cancer Research and Neurology. According to data from OpenAlex, Thomas Schwarzl has authored 31 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Neurology. Recurrent topics in Thomas Schwarzl's work include RNA Research and Splicing (19 papers), RNA modifications and cancer (18 papers) and RNA and protein synthesis mechanisms (17 papers). Thomas Schwarzl is often cited by papers focused on RNA Research and Splicing (19 papers), RNA modifications and cancer (18 papers) and RNA and protein synthesis mechanisms (17 papers). Thomas Schwarzl collaborates with scholars based in Germany, Ireland and United States. Thomas Schwarzl's co-authors include Matthias W. Hentze, Alfredo Castelló, Thomas Preiß, Juan Valcárcel, Fátima Gebauer, Rastislav Horos, Jeroen Krijgsveld, Anne-Marie Alleaume, Tomaž Curk and Wolfgang Huber and has published in prestigious journals such as Cell, Nucleic Acids Research and Nature Communications.

In The Last Decade

Thomas Schwarzl

30 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A brave new world of RNA-binding proteins

2018 1.2k citations Matthias W. Hentze, Alfredo Castelló et al. Nature Reviews Molecular Cell Biology profile →
RNA-binding proteins in human genetic disease

2020 517 citations Fátima Gebauer, Thomas Schwarzl et al. Nature Reviews Genetics profile →

Peers

Countries citing papers authored by Thomas Schwarzl

Since Specialization

Citations

This map shows the geographic impact of Thomas Schwarzl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Schwarzl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Schwarzl more than expected).

Fields of papers citing papers by Thomas Schwarzl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Schwarzl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Schwarzl. The network helps show where Thomas Schwarzl may publish in the future.

Co-authorship network of co-authors of Thomas Schwarzl

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Schwarzl. A scholar is included among the top collaborators of Thomas Schwarzl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Schwarzl. Thomas Schwarzl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cytosolic RNA binding of the mitochondrial TCA cycle enzyme malate dehydrogenase (MDH2) 2024 ·RNA ·(unknown), (unknown), (unknown), Thomas Schwarzl, Matthias W. Hentze	0
2	Transcriptional profiling of early differentiation of primary human mesenchymal stem cells into chondrocytes 2023 ·Scientific Data ·Thomas Schwarzl, (unknown), Georgina Shaw, Aleksandar Krstić, Elizabeth Clayton, Desmond G. Higgins, Walter Kölch, Frank Barry	8
3	The RNA-binding protein landscapes differ between mammalian organs and cultured cells 2023 ·Nature Communications ·Joel I. Perez-Perri, Dunja Ferring–Appel, Ina Huppertz, Thomas Schwarzl, Sudeep Sahadevan, Frank Stein, Mandy Rettel, Bruno Galy, Matthias W. Hentze	22
4	Riboregulation of Enolase 1 activity controls glycolysis and embryonic stem cell differentiation 2022 ·Molecular Cell ·Ina Huppertz, Joel I. Perez-Perri, (unknown), (unknown), Thomas Schwarzl, (unknown), Dunja Ferring–Appel, (unknown), Lyudmila Dimitrova-Paternoga, Eleni Kafkia, Janosch Hennig, Pierre Neveu, Kiran Raosaheb Patil, Matthias W. Hentze	73
5	Small noncoding RNA interactome capture reveals pervasive, carbon source–dependent tRNA engagement of yeast glycolytic enzymes 2022 ·RNA ·Claudio Asencio, Thomas Schwarzl, Sudeep Sahadevan, Matthias W. Hentze	3
6	A Pipeline for Analyzing eCLIP and iCLIP Data with Htseq-clip and DEWSeq 2021 ·Methods in molecular biology ·Sudeep Sahadevan, (unknown), Thomas Schwarzl	4
7	Plasticity of nuclear and cytoplasmic stress responses of RNA-binding proteins 2020 ·Nucleic Acids Research ·Michael Backlund, Frank Stein, Mandy Rettel, Thomas Schwarzl, Joel I. Perez-Perri, (unknown), Yang Zhou, Gabriele Neu‐Yilik, Matthias W. Hentze, Andreas E. Kulozik	41
8	RNA-binding proteins in human genetic disease breakdown → 2020 ·Nature Reviews Genetics ·Fátima Gebauer, Thomas Schwarzl, Juan Valcárcel, Matthias W. Hentze	517
9	The RNA-Binding Protein YBX3 Controls Amino Acid Levels by Regulating SLC mRNA Abundance 2019 ·Cell Reports ·Amy Cooke, Thomas Schwarzl, Ina Huppertz, Gertjan Kramer, (unknown), Anne-Marie Alleaume, Wolfgang Huber, Jeroen Krijgsveld, Matthias W. Hentze	47
10	The Small Non-coding Vault RNA1-1 Acts as a Riboregulator of Autophagy 2019 ·Cell ·Rastislav Horos, Magdalena Büscher, Rozemarijn Kleinendorst, Anne-Marie Alleaume, Abul K. Tarafder, Thomas Schwarzl, Dmytro Dziuba, Christian Tischer, Elisabeth M. Zielonka, (unknown), Alfredo Castelló, Wolfgang Huber, Carsten Sachse, Matthias W. Hentze	122
11	A brave new world of RNA-binding proteins breakdown → 2018 ·Nature Reviews Molecular Cell Biology ·Matthias W. Hentze, Alfredo Castelló, Thomas Schwarzl, Thomas Preiß	1168
12	The Human RNA-Binding Proteome and Its Dynamics during Translational Arrest 2018 ·Cell ·Jakob Trendel, Thomas Schwarzl, Rastislav Horos, Ananth Prakash, Alex Bateman, Matthias W. Hentze, Jeroen Krijgsveld	280
13	Retinoic acid and TGF-β signalling cooperate to overcome MYCN-induced retinoid resistance 2017 ·Genome Medicine ·David J. Duffy, Aleksandar Krstić, Melinda Halász, Thomas Schwarzl, Anja Konietzny, Kristiina Iljin, Desmond G. Higgins, Walter Kölch	29
14	Exon Junction Complexes Show a Distributional Bias toward Alternatively Spliced mRNAs and against mRNAs Coding for Ribosomal Proteins 2016 ·Cell Reports ·Christian Hauer, (unknown), Thomas Schwarzl, Ina Hollerer, Tomaž Curk, Anne-Marie Alleaume, Matthias W. Hentze, Andreas E. Kulozik	55
15	The RNA-binding proteomes from yeast to man harbour conserved enigmRBPs 2015 ·Nature Communications ·Benedikt M. Beckmann, Rastislav Horos, Bernd Fischer, Alfredo Castelló, Katrin Eichelbaum, Anne-Marie Alleaume, Thomas Schwarzl, Tomaž Curk, (unknown), Wolfgang Huber, Jeroen Krijgsveld, Matthias W. Hentze	341
16	FASTKD2 is an RNA-binding protein required for mitochondrial RNA processing and translation 2015 ·RNA ·Johannes Popow, Anne-Marie Alleaume, Tomaž Curk, Thomas Schwarzl, Sven W. Sauer, Matthias W. Hentze	78
17	Improved binding site assignment by high-resolution mapping of RNA–protein interactions using iCLIP 2015 ·Nature Communications ·Christian Hauer, Tomaž Curk, Simon Anders, Thomas Schwarzl, Anne-Marie Alleaume, (unknown), Ina Hollerer, (unknown), Wolfgang Huber, Matthias W. Hentze, Andreas E. Kulozik	26
18	GSK3 Inhibitors Regulate MYCN mRNA Levels and Reduce Neuroblastoma Cell Viability through Multiple Mechanisms, Including p53 and Wnt Signaling 2013 ·Molecular Cancer Therapeutics ·David J. Duffy, Aleksandar Krstić, Thomas Schwarzl, Desmond G. Higgins, Walter Kölch	71
19	c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway 2011 ·Cancer Research ·Jens Rauch, Kim Moran‐Jones, Valérie Albrecht, Thomas Schwarzl, Keith D. Hunter, Olivier Gires, Walter Kölch	51
20	GeneSigDB—a curated database of gene expression signatures 2009 ·Nucleic Acids Research ·Aedín C. Culhane, Thomas Schwarzl, Răzvan Sultana, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Mick Correll, John Quackenbush	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact